Related Experiment Video
Updated: May 10, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Overexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activation
1The Research Center for Medical Genomics, MOH Key Laboratory of Cell Biology and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang 110001, China.
Abstract:
DOC-1R (deleted in oral cancer-1 related) is a novel putative tumor suppressor. This study investigated DOC-1R antitumor activity and the underlying molecular mechanisms. Cell phenotypes were assessed using flow cytometry, BrdU incorporation and CDK2 kinase assays in DOC-1R overexpressing HeLa cells. In addition, RT-PCR and Western blot assays were used to detect underlying molecular changes in these cells. The interaction between DOC-1R and CDK2 proteins was assayed by GST pull-down and immunoprecipitation-Western blot assays. The data showed that DOC-1R overexpression inhibited G1/S phase transition, DNA replication and suppressed CDK2 activity. Molecularly, DOC-1R inhibited CDK2 expression at the mRNA and protein levels, and there were decreased levels of G1-phase cyclins (cyclin D1 and E) and elevated levels of p21, p27, and p53 proteins. Meanwhile, DOC-1R associated with CDK2 and inhibited CDK2 activation by obstructing its association with cyclin E and A. In conclusion, the antitumor effects of DOC-1R may be mediated by negatively regulating G1 phase progression and G1/S transition through inhibiting CDK2 expression and activation.
Insights
Deleted in oral cancer-1 related (DOC-1R) protein acts as a tumor suppressor by inhibiting cell cycle progression. DOC-1R overexpression halts DNA replication and suppresses CDK2 activation, crucial for cancer cell growth.
Area of Science:
- Oncology
- Molecular Biology
- Cell Cycle Regulation
Background:
- The deleted in oral cancer-1 related (DOC-1R) protein is a novel, putative tumor suppressor.
- Understanding DOC-1R's role in cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the antitumor activity of DOC-1R.
- To elucidate the molecular mechanisms underlying DOC-1R's tumor-suppressive functions.
Main Methods:
- Overexpression of DOC-1R in HeLa cells.
- Cell cycle analysis using flow cytometry and BrdU incorporation.
- Assessment of CDK2 kinase activity.
- Gene and protein expression analysis via RT-PCR and Western blotting.
- Protein-protein interaction studies (GST pull-down, immunoprecipitation).
Main Results:
- DOC-1R overexpression inhibited G1/S phase transition and DNA replication.
- DOC-1R suppressed CDK2 activity, expression (mRNA and protein), and activation.
- DOC-1R overexpression led to decreased levels of cyclin D1 and E, and increased levels of p21, p27, and p53.
- DOC-1R directly associated with CDK2, hindering its interaction with cyclin E and A.
Conclusions:
- DOC-1R exhibits antitumor effects by inhibiting cell cycle progression.
- DOC-1R negatively regulates the G1 phase and G1/S transition by suppressing CDK2 expression and activation.
More Related Videos
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules
DNA Damage can Stall the Cell Cycle